STAFF

Dr. Pedro Zapater Hernández

Professor of Pharmacology, Universidad Miguel Hernandez
Clinical Pharmacologist, School of Medicine, Universidad Miguel Hernández

]

Unit
Pharmacology, Pediatrics and Organic Chemistry

^

Subunit
Clinical Pharmacology

Group
Immunopharmacology

pzapater@goumh.umh.es

+ 34 965 91 38 96

RESEARCH FIELDS 

  • Nervous and immune regulation of inflammatory process.
  • Inflammation and stress in the pathogenesis of cancer.
  • Use of drugs in special populations: cirrhosis, pancreatitis, inflammatory bowel disease.

PROFESSIONAL BACKGROUND

  • Previous positions:
  • Postdoctoral positions:
  • PhD in Medicine.
  • Degree in Medicine.

REPRESENTATIVE PUBLICATIONS

zapater P., et al. (2019)

Inflammatory Bowel Diseases, DOI: 10.1093/ibd/izz041

The Inflammatory Bowel Disease Symptom Inventory: A Patient-report Scale for Research and Clinical Application.

Giménez p., et al. (2018)

Liver International, DOI: 10.1111/liv.13890

Treatment with non‐selective beta‐blockers affects the systemic inflammatory response to bacterial DNA in patients with cirrhosis.

Roca r., et al. (2018)

Molecular Medicine Reports, DOI: 10.3892/mmr.2018.8820

β2‑adrenergic receptor functionality and genotype in two different models of chronic inflammatory disease: Liver cirrhosis and osteoarthritis.

Martínez-Cardona C., et al. (2018)

International Journal of Cancer, DOI: 10.1002/ijc.31827

AIM2 deficiency reduces the development of hepatocellular carcinoma in mice.

Piñero P., et al. (2017)

Scientific Reports, DOI: 10.1038/srep46425

Toll-like receptor polymorphisms compromise the inflammatory response against bacterial antigen translocation in cirrhosis.

Fuster-Lluch O., et al. (2017)

The Journal of Clinical Pharmacology, DOI: 10.1002/jcph.903

Pharmacokinetic Study of Intravenous Acetaminophen Administered to Critically Ill Multiple-Trauma Patients at the Usual Dosage and a New Proposal for Administration.

Juanola O., et al. (2016)

Liver International, DOI: 10.1111/liv.13172

Selective intestinal decontamination with norfloxacin enhances a regulatory T cell-mediated inflammatory control mechanism in cirrhosis.

Zapater P., et al. (2012)

PLoS One, DOI: 10.1371/journal.pone.0043371

Beta-Adrenergic Receptor 1 Selective Antagonism Inhibits Norepinephrine-Mediated TNF-Alpha Downregulation in Experimental Liver Cirrhosis.

COMPANY AGREEMENTS

  • Contracts and agreements of collaboration with companies for the study of inflammation and immune response in chronic pathologies such as osteoarthritis (BIOIBERICA).